Pharmaceutical Manufacturing and Biomedical Research - Overview and Outlook

Pharmaceutical Manufacturing and Biomedical Research - Overview and Outlook

2025-03-19T21:30:00+00:00

2025-03-20T00:00:00+00:00

https://epflalumni.ch//medias/image/thumbnail_209498104667d41edeb46f0.png

The EPFL Alumni NYC Chapter is organizing a new event!Pharmaceutical Manufacturing and Biomedical ResearchOverview and OutlookDate & TimeWednesday, March 19, 20255:30 PM - 8:00 PM ESTLocationThe Rockefeller University, at the Carson Family Auditorium1230 York AvenueNew York, NY 10065ReservationPlease use this Eventbrite link. It's free.ThemeThe EPFL Alumni NYC Chapter is partnering with the Rockefeller University to bring you a promising event about the state of pharmaceutical manufacturing and biomedical research.We will have exclusive insights from Johnson & Johnson’s VP of Manufacturing,  Leila Schwery, followed by a panel discussion with trailblazers in biomedical research. The panel will include EPFL alumni Leila Schwery, the CEO and founder of Neurosoft Bioelectronics (a medtech startup from EPFL), Nicolas Vachicouras, who recently set a new record in neurotechnology for epilepsy monitoring, and Elisabeth Nyakatura, Associate Director for Antibody Engineering, from the Tri-Institutional Therapeutic Discovery Institute from the Rockefeller University.From research and innovation to industrial manufacturing, this event will be the opportunity to discover different aspects of those industries, connect the dots between the different fields, ask questions to the panelists, and network. We will also discuss the different career paths they each chose. AgendaTopicIntervenantIntroduction - EPFL Alumni NYC ChapterJulien HamiltonMouna BarcaWelcome - The Rockefeller UniversityElisabeth NyakaturaPresentation of Johnson & Johnson and the Innovative Medicine GroupLeila SchweryPanel with Leila Schwery (Johnson & Johnson), Nicolas Vachicouras (Neurosoft Bioelectronics), and Elisabeth Nyakatura (Tri-Institutional Therapeutics Discovery Institute at The Rockefeller University)Leila SchweryNicolas VachicourasElisabeth NyakaturaQ & A and NetworkingAllOur Speakers Leila SchweryVP Manufacturing & Technical Operations, Johnson & Johnson Innovative Medicine |  LinkedInA Chemical Engineer by training, Leila has 25 years of professional experience in Switzerland, Germany, Ireland and USA at Novartis, Elanco,  and Johnson & Johnson in the Pharmaceutical and Animal Health sectors.She worked in many areas of supply chain, and has been in global executive positions for the past 15 years with responsibility for Quality, Global Manufacturing and Value Chain Management.Born in Switzerland and raised between Switzerland, Lebanon and Saudi Arabia, she enjoys working with diverse cultures.She now leads the manufacturing organisation for the Johnson & Johnson's Pharmaceutical in Zug, Switzerland, which includes the internal and external manufacturing network and the technical operations organisation in support of all J&J new and existing Pharmaceutical products.Nicolas VachicourasCEO & Co-Founder at Neurosoft Bioelectronics | LinkedInNicolas is the CEO and the co-founder of Neurosoft Bioelectronics, a company that builds minimally invasive brain interfaces to monitor, treat, and restore lost functions for individuals fighting neurological disorders, such as severe tinnitus or upper-limb motor disabilities. The company has been founded at EPFL in 2019, and became independent in 2022. It is based in Geneva, Switzerland, and employs 14 people.Nicolas got his Master Degree in Microengineering in 2014, and his PhD in Microelectronics and Nanosystems in 2019, both obtained at EPFL.Elisabeth NyakaturaSenior Associate Director Antibody Engineering | LinkElisabeth is heading the Antibody Engineering team at the Sanders Tri-Institutional Therapeutic Discovery Institute (Tri-I TDI) in New York, bridging partnerships in academia and industry to develop antibody-based therapies. In this role, she oversees the generation and optimization of biologics drug candidates, leads therapeutic antibody discovery programs, and coaches a functional team of scientists. Prior to joining TDI, Elisabeth was an Assistant Professor at the Albert Einstein College of Medicine. Her work guided the development of antiviral antibodies. Elisabeth is passionate about fostering a culture of innovation to deliver safe and efficacious new medicines.We look forward to meeting you!Mouna Barca (SC'13) & Julien Hamilton (IN'07)For the EPFL Alumni NYC Chapter

https://epflalumni.ch/fr/event/pharmaceutical-manufacturing-and-biomedical-research-overview-and-outlook/2025/03/19/898